BELEN RUIZ-ANTORAN
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Outcomes Of The Spanish Cohort Of Early Access To Pertuzumab And Trastuzumab Emtansine (NCT03025711) | BELEN RUIZ-ANTORAN | 2017-12-01 |
Track BELEN RUIZ-ANTORAN automatically
Every clearance here is in the API, with alerts when new ones post.